Andrei L Gartel (Andrei Gartel, A L Gartel)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 13

Top Topics

Acute Myeloid Leukemia

Gene Expression

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Blood cancer journal

Cell death discovery

Research square

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Sanjeev Raghuwanshi, Xu Zhang, Zarema Arbieva, Irum Khan, Hisham Mohammed, Z Wang, Alexander Domling, Carlos Jaime Camacho, Andrei L Gartel
Novel FOXM1 inhibitor STL001 sensitizes human cancers to a broad-spectrum of cancer therapies. Cell death discovery 10 (1) (2024)
Irum Khan, Mohammed A Amin, Elizabeth A Eklund, Andrei L Gartel
Regulation of HOX gene expression in AML. Blood cancer journal 14 (1) (2024)
Irum Khan, Mohammed A Amin, Elizabeth A Eklund, Andrei L Gartel
Regulation of HOX gene expression in AML. Blood cancer journal 14 (1) (2024)
Irum Khan, Mohammed A Amin, Elizabeth A Eklund, Andrei L Gartel
Regulation of HOX gene expression in AML. Blood cancer journal 14 (1) (2024)
Sanjeev Raghuwanshi, Xu Zhang, Zarema Arbieva, Irum Khan, Hisham Mohammed, Z Wang, Alexander Domling, Carlos Jaime Camacho, Andrei L Gartel
Novel FOXM1 inhibitor STL001 sensitizes human cancers to a broad-spectrum of cancer therapies. Cell death discovery 10 (1) (2024)
Sanjeev Raghuwanshi, Xu Zhang, Zarema Arbieva, Irum Khan, Hisham Mohammed, Z Wang, Alexander Domling, Carlos Jaime Camacho, Andrei L Gartel
Novel FOXM1 inhibitor STL001 sensitizes human cancers to a broad-spectrum of cancer therapies. Cell death discovery 10 (1) (2024)
Irum Khan, Mohammed A Amin, Elizabeth A Eklund, Andrei L Gartel
Regulation of HOX gene expression in AML. Blood cancer journal 14 (1) (2024)
Irum Khan, Mohammed A Amin, Elizabeth A Eklund, Andrei L Gartel
Regulation of HOX gene expression in AML. Blood cancer journal 14 (1) (2024)
Sanjeev Raghuwanshi, Xu Zhang, Zarema Arbieva, Irum Khan, Hisham Mohammed, Z Wang, Alexander Domling, Carlos Jaime Camacho, Andrei L Gartel
Novel FOXM1 inhibitor STL001 sensitizes human cancers to a broad-spectrum of cancer therapies. Cell death discovery 10 (1) (2024)
Irum Khan, Mohammed A Amin, Elizabeth A Eklund, Andrei L Gartel
Regulation of HOX gene expression in AML. Blood cancer journal 14 (1) (2024)
Andrei L Gartel, Sanjeev Raghuwanshi, Xu Zhang, Zarema Arbieva, Irum Khan, Zefeng Wang, Alex Domling, Carlos Jaime Camacho
Novel FOXM1 inhibitor STL001 sensitizes human cancers to a broad-spectrum of cancer therapies. Research square (2023)
Irum Khan, A Kaempf, Sanjeev Raghuwanshi, Mikhail S Chesnokov, X Zhang, Z Wang, A Domling, Jeffrey W Tyner, C Camacho, Andrei L Gartel
Favorable outcomes of NPM1 mut AML patients are due to transcriptional inactivation of FOXM1, presenting a new target to overcome chemoresistance. Blood cancer journal 13 (1) (2023)
Mikhail S Chesnokov, Marianna Halasi, Soheila Borhani, Zarema Arbieva, Binal N Shah, Rick Oerlemans, Irum Khan, Carlos Jaime Camacho, Andrei L Gartel
Novel FOXM1 inhibitor identified via gene network analysis induces autophagic FOXM1 degradation to overcome chemoresistance of human cancer cells. Cell death & disease 12 (7) (2021)